STOCKHOLM, July 7, 2021 /PRNewswire/ -- Implantica AG (publ) today announces that Klinikum Friedrichshafen in Germany, one of the largest anti-reflux centers, has begun implementing RefluxStop. The hospital has successfully completed several surgeries with RefluxStop performed by Prof. Dr. med. Lehmann and his team.
"We welcome the adoption of the RefluxStop surgical procedure by another prominent anti-reflux center and renowned surgeon in Germany, and we look forward to working together with Prof. Dr. med. Lehmann. We anticipate more and more centers to begin with RefluxStop as the effects of COVID-19 ease," said Peter Forsell, CEO of Implantica.
For further information, please contact:
Nicole Pehrsson, Investor Relations
Telephone (CH): +41 (0)79 335 09 49
nicole.pehrsson@implantica.com
Implantica is listed on Nasdaq First North Premier Growth Market in Stockholm.
The company's Certified Adviser is FNCA Sweden AB, +46 (0)8 528 00 399, info@fnca.se
The information was sent for publication, through the agency of the contact person set out above, on July 07, 2021 at 08:30 a.m. CET.
About Implantica
Implantica is a medtech group dedicated to bringing advanced technology into the body. Implantica's lead product, RefluxStop, is a CE-marked implant for the prevention of gastroesophageal reflux that will potentially create a paradigm shift in anti-reflux treatment as supported by successful clinical trial results. Implantica also focuses on eHealth inside the body and has developed a broad, patent protected, product pipeline based partly on two platform technologies: an eHealth platform designed to monitor a broad range of health parameters, control treatment from inside the body and communicate to the caregiver on distance and a wireless energising platform designed to power remote controlled implants wirelessly through intact skin. Implantica is listed on Nasdaq First North Premier Growth Market (ticker: IMP A SDB). Visit www.implantica.com for further information.
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/implantica/r/implantica-announces-that-another-prominent-anti-reflux-center-has-started-operating-with-implantabl,c3381130
The following files are available for download:
https://mb.cision.com/Main/19732/3381130/1441948.pdf | Implantica announces that another prominent anti-reflux center has started operating with implantable medical device RefluxStop' |
